Fluoride Treatment and Risk of Fracture In Osteoporosis Patients

Simple item page
dc.contributor.authorAlshikhi, Sara Almabrouk
dc.date.accessioned2018-05-21T14:28:36Z
dc.date.available2018-05-21T14:28:36Z
dc.date.issued2018-03-14
dc.descriptionOsteoporosis is common systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk” • More common in postmenopausal Sodium fluoride stimulates bone formation and increases cancellous-bone mass Sodium fluoride (NaF) was currently the only pharmacological agent capable of stimulating bone formation through a direct effect on the osteoblasten_US
dc.identifier.urihttp://repository.limu.edu.ly/handle/123456789/275
dc.language.isoenen_US
dc.publisherfaculty of Basic Medical Science - Libyan International Medical Universityen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleFluoride Treatment and Risk of Fracture In Osteoporosis Patientsen_US
dc.typeOtheren_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
poster-sara-sara-2.pdf
Size:
683.66 KB
Format:
Adobe Portable Document Format
Description:
Sodium fluoride stimulates bone formation and increases cancellous-bone mass Sodium fluoride (NaF) was currently the only pharmacological agent capable of stimulating bone formation through a direct effect on the osteoblast
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.74 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Posters